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Liver natural killer (NK) cells were recently reported to possess memory-like properties in contact hypersensitivity (CHS) models. However, the phenotype and origin of these “memory” NK cells cannot be distinguished
from other NK cell subpopulations. Here, we define the transcriptional, phenotypic, and functional features
of liver NK cell subsets and their roles in mediating CHS. Liver NK cells can be divided into two distinct subsets: CD49a+DX5– and CD49a–DX5+. Substantial transcriptional and phenotypic differences existed between
liver CD49a+DX5– NK cells and other NK cell subsets. CD49a+DX5– NK cells possessed memory potential and
conferred hapten-specific CHS responses upon hapten challenge. Importantly, CD49a+DX5– NK cells were
liver resident and were present in the liver sinusoidal blood, but not the afferent and efferent blood of the liver.
Moreover, they appeared to originate from hepatic hematopoietic progenitor/stem cells (HPCs/HSCs) but not
from the bone marrow, and maintained their phenotypes in the steady state. Our findings of liver-resident NK
cells shed new light on the acquisition of memory-like properties of NK cells.
Introduction
Natural killer (NK) cells are important components of the innate
immune system (1–3). Unlike T and B cells, NK cells efficiently exert
their effector functions, classically without the necessity of prior
sensitization, and mainly through direct cytotoxicity and the production of various cytokines, thus providing the first line of defense
against pathogens and tumors. NK cells are thought to develop
primarily in the bone marrow (BM) during adult life (4, 5), and NK
cell maturation is a multistep process associated with progressive
acquisition and/or downregulation of a series of markers (6). NK cell
precursors (NKPs), expressing CD122 and lacking NK cell–specific
markers, are traditionally defined as comprising the first stage of NK
lineage commitment and can give rise to immature NK cells after
acquisition of NK 1.1 in C57BL/6 (B6) mice (7). Immature NK cells
further differentiate into mature NK cells, involving the sequential
expression of DX5 (CD49b), CD11b, KLRG1, and CD27 (6, 8–10).
Although mature NK cells represent the main NK cell population in
the peripheral organs, there is accumulating evidence that phenotypically immature NK cells are not unique to the BM, suggesting that
NK cell development may also take place at peripheral sites (11–13)
or that these cells may represent distinct NK cell subsets.
As innate immune effectors, NK cells have long been considered to
lack immunological memory, a hallmark of adaptive immune cells.
NK cells do not express recombination-activating gene (RAG) proteins, which are necessary for recombination events that are required
to generate a large repertoire of diverse antigen-specific receptors in
T and B cells (14, 15). Strikingly, however, recent findings demonstrated that NK cells can mount a robust recall response following
specific activation by chemical haptens (16–18) or viruses (17, 19,
20), or nonspecific activation by cytokines (21), respectively. Among
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the NK cells examined for apparent “antigen-specific” responses,
hepatic but not splenic NK cells confer hapten- or virus-specific
responses, whereas conventional splenic NK cells can mediate
memory-like effects following murine cytomegalovirus (MCMV)
and cytokine stimulation (19, 21). Particularly, in contact hypersensitivity (CHS) and non-MCMV studies, hapten- and virus-specific
“memory” liver NK cells express Ly49C/I (16), CXCR6 (17), and/or
Thy1 (20). However, these molecules are expressed on other cells,
including splenic NK cells (1, 15). Therefore, liver NK cells endowed
with memory-like properties do not have a phenotype that can distinguish them from other NK cells.
On the other hand, previous studies have suggested that liver
NK cells may be phenotypically distinct from conventional splenic
NK cells, which in turn resemble NK cells in peripheral blood. For
example, the liver contains an unusually high proportion (up to
50%) of phenotypically immature NK cells, expressing TNF-related
apoptosis-inducing ligand (TRAIL) and lacking DX5 (6, 11, 22),
whereas NK cells at other peripheral sites are predominantly
mature in phenotype and function. Notably, during early life, the
phenotypically immature NK cells are predominant in the liver
and can also be found in the spleen (11). In contrast to the sharp
decline of these NK cells in the spleen after birth, in the liver they
only mildly decrease with age and maintain a stable subpopulation
in adult mice (11). Finally, these liver NK cells have relatively low
proliferative capacity in the steady state (22). Thus, these studies
suggest that there may be an organ-specific, i.e., liver-specific, NK
cell population endowed with memory-like properties and distinguishable from conventional NK cells in the spleen and peripheral
circulation, perhaps akin to thymic NK cells (13).
Challenges to identifying such a putative liver-specific NK cell
subpopulation relate to several unique aspects of the liver, including two afferent vascular supplies and distinctive immunological features. Through the portal vein that drains the abdominal organs including the spleen, the liver receives about 75% of
its afferent blood, exposing the liver to a variety of antigens and
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Figure 1
Hepatic DX5– NK cells confer memory responses in CHS. (A) Expression of DX5 versus NK1.1 was analyzed on CD122+CD3–CD19– cells from
liver, spleen, peripheral blood, BM, and iLNs of WT B6 mice. Representative FACS plots are shown. (B) The percentages of DX5– NK cells among
NK (CD122+NK1.1+CD3–CD19–) cells in different organs are shown (n = 7). (C) Ear swelling in naive B6 mice that received 8 × 104 DX5+ (n = 6)
or DX5– (n = 4) NK (NK1.1+ CD3– CD19–) cells from OXA-sensitized Rag1−/− donor liver. Recipients were challenged 1 month later with OXA on
1 ear and solvent on the other. (D) Ear swelling in naive B6 mice that received 8 × 104 hepatic NK cell subsets (n = 3 per group) or splenic NK
cells (n = 6) from OXA-sensitized WT mice and were challenged 1 month later. (C and D) Data are from 1 experiment representative of at least 2
independent experiments. **P < 0.01; ***P < 0.001. Unpaired Student’s t test (C) or ANOVA (D). Means ± SEM are shown in B–D.

microbial products from the gastrointestinal tract. This nutrient-rich blood mixes with oxygenated blood from the hepatic
artery in the sinusoids, a highly fenestrated, low-pressure vascular
system containing many innate immune cells, especially NK cells.
Interestingly, NK cells are difficult to identify on liver tissue sections, consistent with their residence in the sinusoids rather than
in the liver parenchyma per se (23). Thus, if the liver contains a
liver-resident NK cell population, the cells should reside in the
sinusoids where they are mixed with circulating NK cells, which
may be phenotypically distinguishable.
Herein, we precisely describe the fundamental features of liver-resident NK cells. We characterized their unique phenotype as
CD49a+DX5–, and found that they are involved in the immunological memory response in NK cell–mediated CHS models and that
their hematopoietic progenitor cells (HPCs) and precursors exist
in the liver. Thus, our experiments suggest that liver-resident NK
cells confer memory-like responses in CHS.
Results
Hepatic DX5– NK cells confer CHS responses. Since hepatic NK cells, but
not splenic NK cells, can elicit hapten-specific CHS responses (16, 17),
we hypothesized that the phenomenon was due to a distinct NK cell
subset present in the liver and not in the spleen. One clue to this subset was the description of DX5– NK cells enriched in the liver that were
speculated to be an immature population similar to one identified in
the BM (6). Here, we examined the expression of DX5 and NK1.1 on
CD122+CD3–CD19– cells from different organs in B6 mice (Figure 1,
A and B). Consistent with previous findings, DX5–NK1.1– cells resem-

bling NKPs were detectable in the BM, liver, spleen, and lymph nodes
(12). The DX5+NK1.1+ subset, defined as conventional NK cells, was
abundant in all examined organs. Surprisingly, however, nearly half of
hepatic NK1.1+ NK cells were DX5–, whereas approximately 5%–8% of
NK1.1+ NK cells in other organs were DX5–.
To test the potential role of the DX5– subset in CHS, we sensitized Rag1–/– or WT mice with oxazolone (OXA) then adoptively
transferred their DX5– or DX5+ liver NK cells into naive WT recipients. One month later, recipients were challenged with OXA and
ear swelling was measured. Only recipients that received sensitized hepatic DX5– NK cells displayed marked ear inflammation,
whereas recipients of sensitized hepatic DX5+ NK cells or sensitized splenic NK cells were unresponsive (Figure 1, C and D). Thus,
the immunological memory capacity of liver NK cells in CHS
models can be attributed to hepatic DX5– NK cells, suggesting that
hepatic DX5– NK cells are functionally distinct from hepatic DX5+
and splenic NK cells, potentially as a unique subset.
“Memory” NK cells remain DX5– during hapten priming in the liver. To
verify whether the sensitized “memory” NK cells are naive hepatic
DX5– NK cells, but not differentiated from other NK cell subsets
including both non-liver NK cells and DX5+ NK cells, we transferred naive hepatic DX5– or DX5+ NK cells sorted from GFP transgenic mice into lethally irradiated recipients followed by sensitization with OXA at days 1 and 2. The liver mononuclear cells (MNCs)
from the lethally irradiated recipients were isolated at day 5 (before
irradiation-induced death), and adoptively transferred by intravenous injection into secondary naive recipients, which was followed
by challenge 1 month later (Figure 2A). Before secondary transfer,
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Figure 2
Hepatic NK cells with memory capacity remain DX5– during hapten sensitization. (A) DX5– or DX5+ NK (NK1.1+CD3–CD19–) cells (105) from naive
GFP transgenic mice were adoptively transferred into lethally irradiated recipients, which were sensitized with 5% OXA on days 1 and 2. On day
5, liver MNCs from recipients or control irradiated mice that did not receive any cells were adoptively transferred into secondary recipients that
were challenged 1 month later. (B) DX5 expression on GFP+ NK cells in the irradiated recipients that received GFP+DX5– (top panel) or GFP+DX5+
(bottom panel) NK cells was analyzed on day 5 before transfer. (C) Ear swelling of secondary recipients described in A was measured after OXA
challenge (n = 5 per group). ***P < 0.001, ANOVA. Means ± SEM are shown. Hepatocytes (D) or F4/80+ Kupffer cells (E) in the liver of sensitized
(blue) or control (gray shaded) WT mice were respectively isolated by a 2-step collagenase perfusion method, then gated and analyzed for FITC
expression; the statistical results show FITC MFI on sensitized (n = 6) or control (n = 2) hepatocytes. *P < 0.05, unpaired Student’s t test. Means
± SEM are shown. (F) FITC+ cells in Rag1–/– mice 24 hours after sensitization of FITC on 2 consecutive days. Rag1–/– mice without sensitization
were set as controls. FITC+ cells among liver MNCs from sensitized mice were analyzed for the expression of indicated markers. (B–F) Data are
representative of 2 or 3 independent experiments. SSC, side scatter.

donor GFP+DX5– NK cells in irradiated recipients remained DX5–
following sensitization with OXA, and donor GFP+DX5+ NK cells
consistently maintained expression of DX5 (Figure 2B), indicating
that hapten sensitization did not affect DX5 expression on NK
cells. Importantly, we found that only secondary recipients that
received liver MNCs from the first sensitized recipients, which in
turn had received naive hepatic DX5– NK cells, could mount hap1446

ten-specific CHS responses (Figure 2C). These results demonstrate
that only naive hepatic DX5– NK cells, not other NK cell subsets,
have memory potential.
Taken together with the rarity of naive DX5– NK cells in peripheral tissues except the liver, these findings raise the possibility
that the liver may be a site where naive NK cells are primed, in
which case haptens would need to be delivered to the liver to elicit

The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 4   April 2013

Downloaded on October 19, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/66381

research article

Figure 3
Hepatic DX5– NK cells preferentially traffic to the liver and maintain their phenotypic features after adoptive transfer. (A) Liver MNCs (106) from
CD45.1+ mice were adoptively transferred intravenously into sublethally irradiated (IR) CD45.2+ B6 mice. Twenty-four hours after transfer, CD45.1+
NK (NK1.1+CD3–CD19–) cells were analyzed for DX5 expression in recipient liver, spleen, and BM. (B) DX5– or DX5+ liver NK cells (105) were
sorted from CD45.1+ mice and intravenously transferred into sublethally irradiated CD45.2+ B6 mice. DX5 expression of donor NK cells before
transfer is shown pre- and post-sort. Seven days after transfer, CD45.1+ NK cells were analyzed for DX5 expression in recipient liver and spleen.
All data in this figure are representative of 2 independent experiments.

CHS responses. To examine this hypothesis, we sensitized naive
WT mice with the hapten FITC and found that FITC fluorescence on hepatocytes of sensitized mice was detected as opposed
to normal autofluorescence of hepatocytes (Figure 2D), implying
that hepatocytes may absorb haptens after sensitization and consistent with the liver as a possible site for hapten sensitization.
However, Kupffer cells, the resident macrophages in the liver,
seemed less likely to be involved in this process, as FITC+ expression was only very rarely detectable in the Kupffer cell population
(Figure 2E). Accordingly, FITC-laden cells infiltrated the liver,
but there were no FITC+ cells in the spleen in FITC-sensitized
Rag1–/– mice (Figure 2F). Phenotypic assessment of these liver
FITC+ cells revealed that they were NK1.1loLy6Glo cells, with some
cells expressing CD11c and CD11b. Further analysis showed that
double-positive CD11b+CD11c+ cells existed among FITC+ cells,
suggestive of the involvement of dendritic cells in NK cell priming. Also, CD11b+F4/80+Gr-1+ cells with monocyte phenotypes
were observed, indicating that circulating macrophages may also
function as APCs. Thus, the retention of circulating cells with antigen-presenting ability in the liver makes it possible that DX5– NK
cells are directly primed in the liver.
Preferential trafficking of DX5– NK cells to the liver without further differentiation. In our initial studies to investigate whether DX5– NK
cells selectively reside in the liver, we adoptively transferred unseparated liver MNCs from CD45.1+ mice into sublethally irradiated
CD45.2+ recipients via intravenous injection. One day after transfer, we found that donor-derived DX5– NK cells accumulated only
in the liver, whereas donor-derived DX5+ NK cells showed distribution to other sites (Figure 3A), suggestive of distinct migratory
tendencies between these 2 subsets. However, it is possible that this
result is due to rapid conversion from DX5– to DX5+ NK cells in
various tissues except the liver, and that there is no intrinsic difference between them in migratory capacity. To further determine

whether they differ in tissue migration, we adoptively transferred
sorted DX5– and DX5+ liver NK cells and analyzed recipient mice;
we consistently found that donor-derived DX5– NK cells were only
detected in the host liver, whereas donor-derived DX5+ NK cells
were found in both the host liver and spleen (Figure 3B). To further confirm the preferential migration of DX5– NK cells to the
liver, we used another marker of donor NK cells on the purified
DX5– or DX5+ liver NK cells, i.e., the stable expression of GFP, and
a different route of transfer. Following adoptive transfer into sublethally irradiated recipients via intraperitoneal injection, donor
GFP+DX5– NK cells were only found in the liver (Supplemental
Figure 1; supplemental material available online with this article; doi:10.1172/JCI66381DS1). Moreover, transferred DX5– NK
cells remained DX5– in recipient liver (Figure 3B), suggesting that
hepatic DX5– NK cells are phenotypically stable and do not differentiate into DX5+ NK cells in the steady state. Thus, compared
with nondiscriminatory migration of the DX5+ subset to different
tissues, hepatic DX5– NK cells preferentially traffic to the liver and
have a low capacity to repopulate other tissues after transfer.
The transcriptional, phenotypic, and functional features of hepatic DX5–
NK cells. We next sought to determine other differences between
DX5– and DX5+ NK cells in transcriptional signature, phenotype,
and functional capacity. DX5–NK1.1+ and DX5+NK1.1+ liver NK
cells were respectively sorted for gene expression microarray analysis (GEO accession number GSE43339). With nearly 22,000 genes
tested, 11,122 expressed genes showed no change in DX5– versus
DX5+ NK cells, while 1,507 expressed genes showed a fold change of
2 or greater, among which 566 genes were overexpressed in DX5– NK
cells (Figure 4A). The differentially expressed genes included those
encoding inhibitory and activating receptors, cytokines, chemokines, adhesion molecules, cytokine receptors, cytotoxic effectors,
and transcription factors (Figure 4B). We confirmed several of these
findings by flow cytometry (Supplemental Table 1). Molecules asso-
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Figure 4
Hepatic DX5– NK cells are distinct from other NK cell populations. (A) Comparative
transcriptome analysis between DX5– and DX5+ liver NK (NK1.1+CD3–) cells was
performed by Affymetrix GeneChip Mouse Genome 430 2.0 arrays. Genes that were
expressed greater than or equal to 2-fold higher or lower than DX5+ NK cells are
highlighted in black. The number of genes upregulated or downregulated for each
comparison is indicated. (B) Differentially expressed genes in DX5– and DX5+ NK
cells were selected and classified into different groups. The listed genes had greater
than or equal to 2-fold differences and are shown with their signal values. (C) Distribution by functional category of upregulated genes in hepatic DX5+ and DX5– NK
cell subsets. Genes with greater than or equal to 2-fold differences were included.
(D) Expression of CD107a and IFN-γ is shown for stimulated DX5– and DX5+ liver
NK (NK1.1+CD3–CD19–) cells. Liver MNCs were stimulated with IL-2 and IL-12 (for
IFN-γ analysis) or with YAC-1 cells (for CD107a analysis). Blue lines represent staining of the indicated molecules, and gray-shaded curves represent isotype controls.
(E) Statistical results of percentages of CD107a+ (n = 6) or IFN-γ+ (n = 11) cells are
shown. *P < 0.05 and **P < 0.01, paired Student’s t test. Means ± SEM are shown.
1448
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ciated with adhesion, such as CD49a and CD51, and chemokine
receptors, CXCR3 and CXCR6, were upregulated on DX5– NK cells
at both transcript and protein levels. We consistently found that
CD69 was expressed at higher levels on DX5– NK cells, but not on
S1PR1, which is regulated by CD69 (24). Some adhesion molecules,
such as CD62L (Sell), CD11b (Itgam), CD29 (Itgb1), and CCR9 (Ccr9),
were significantly downregulated on DX5– NK cells. In addition, we
observed that Il21r, Rora, and Ahr, which are related to IL-17 production and Th-17 cell development (25), were also relatively higher in
DX5– NK cells. Eomes, which is implicated in inducing IFN-γ production (26) and NK cell maturation (22), was expressed at much higher
levels in DX5+ NK cells. These differentially expressed transcription
factors may reflect the distinct patterns of cytokines released by
those 2 NK cell subsets. Genes encoding LAG-3, Helios, and Egr-2,
which are preferentially expressed by Treg cells (27–29), were also
found to be overexpressed by DX5– NK cells, raising the possibility
that DX5– NK cells may exert negative regulatory actions within the
liver. Interestingly, Cd3g, which has been previously reported to be
expressed in fetal NK cells (30) was highly expressed in DX5– NK
cells, supporting the possibility of common origins between NK and
T cells. In brief, we found that genes associated with immune tolerance, negative regulation, and activation were enhanced in DX5– NK
cells, while DX5+ NK cells were relatively enriched in genes associated with migration, immune response, proliferation, and cell maturation (Figure 4C and Supplemental Table 2).
Regarding function, effector molecules such as TRAIL (Tnfsf10),
granzyme c (Gzmc), and granzyme f (Gzmf) were overexpressed in
DX5– NK cells, implying that DX5– NK cells are functional. However, stimulation assays showed that DX5– NK cells expressed
markedly lower levels of CD107a, a degranulation marker of cytotoxic NK cells, and produced slightly lower levels of IFN-γ than
DX5+ NK cells after activation (Figure 4, D and E). These data suggest that the 2 NK cell subsets are functionally different. Further
analysis revealed that DX5+ NK cells of the liver phenotypically
resembled those of the spleen (Supplemental Figure 2). Hence,
previous findings that bulk liver NK cells are phenotypically different from NK cells in other organs (6, 11, 31) may be due to the
unique DX5– subset of NK cells in the liver.
As the primary site for NK cell development (4, 5), the BM also
contains a very small subpopulation of DX5– NK cells which were
considered to be immature NK cells (6, 7). Indeed, the low expression of Ly49 receptors and the high expression of NKG2A on liver
DX5– NK cells are consistent with a phenotypically immature
population (6, 31). However, TRAIL was not expressed on BM
DX5– NK cells, in contrast to highly expressed TRAIL on hepatic
DX5– NK cells (ref. 11 and Supplemental Figure 3). Meanwhile,
hepatic DX5– NK cells expressed much higher CD11c than did
BM DX5– NK cells, indicating that hepatic DX5– NK cells are phenotypically different from those of the BM that are considered
to be immature NK cells (7). Taken together, the results indicate
that hepatic DX5– NK cells are distinct from DX5+ NK cells and
DX5– NK cells at other sites in transcriptional, phenotypic, and
functional aspects.
CD49a+DX5– NK cells are liver resident. DX5 is widely used to define
NK cells in mouse strains that are NK1.1– (12), and identification
of DX5– would not be useful as a marker of hepatic NK cell subsets
in such strains, indicating that a “positive marker” to define liver
NK cell subsets is necessary. By transcriptome analysis, we found
that Cd49a, also known as Itga1, was the most highly expressed
gene (20-fold higher) among the top 20 most upregulated genes

in DX5– NK cells (Supplemental Figure 4). Selective expression was
further verified by flow cytometry, showing that CD49a was constitutively and highly expressed by hepatic DX5– NK cells, but not
by hepatic DX5+ NK cells or NK cells from other tissues (Figure
5A). In addition, NKp46, a pan-NK cell marker (32), was expressed
at high levels on both DX5– and DX5+ NK cells. Though CD51
was expressed by the majority of DX5– NK cells, a proportion of
DX5+ NK cells were also CD51+ regardless of tissue origin. The
expression of CD27 and Thy1.2 on NK cells has been reported to
be associated with immune memory by hepatic NK cells (16, 20,
33), but their expression was detected on NK cells from each examined tissue. CXCR6 was found to be required for NK cell–mediated
CHS responses (17), but NK cells from other organs besides liver
also expressed CXCR6, and a fraction of hepatic DX5– NK cells
did not express CXCR6 (Figure 5A), suggesting that it is not an
exclusive marker of liver NK cells. After adoptive transfer, hepatic
DX5– NK cells maintained stable expression of CD49a in recipients, while hepatic DX5+ NK cells were still CD49a– (Figure 5B).
Furthermore, hepatic CD49a+ NK cells were identified in BALB/c and Rag1–/– mice as well as in B6 mice (Figure 5C), and they
were selectively accompanied by high expression of TRAIL, CD51,
CXCR3, LAG3, CD44, and CD2 (Supplemental Figure 5), similar
to what was observed in B6 mice (Supplemental Table 1). Thus,
these results strongly suggest that CD49a+DX5– NK cells represent
an NK cell subset that preferentially resides in the liver.
Importantly, we observed that the CD49a +DX5 – NK cells
resided neither in afferent (arterial or portal venous) nor in efferent (postcaval venous) blood of the liver as opposed to CD49a–
DX5+ NK cells (Figure 5D). Instead, CD49a+DX5– NK cells were
present in the liver sinusoidal blood. Immunofluorescence and
immunohistochemistry further confirmed the localization of
CD49a+ NK cells in the liver sinusoids, albeit somewhat rare on tissue sections (Figure 5, E and F). Moreover, CD49a+DX5– NK cells
were seldom present in the spleen, BM, lung, and lymph nodes
(Figure 5A and data not shown).
Furthermore, we studied unmanipulated CD49a+DX5– and
CD49a–DX5+ NK cells in unirradiated CD45 congenic mice that
were surgically joined by parabiosis. At the time when substantial chimerism of splenic leukocytes (Supplemental Figure 6) was
taking place, the CD49a–DX5+ NK cells from each parabiont were
found in the spleens and livers of both parabionts (Figure 6, A
and B). However, CD49a+DX5– NK cells expressing CD45.1+ were
essentially confined to the CD45.1+ livers which contained few,
if any, CD49a+DX5– NK cells from the CD45.2+ parabiont, and
vice versa. Taken together with the samplings of the liver afferent,
efferent, and sinusoidal vasculature, the preferential migration of
transferred, purified hepatic DX5– NK cells to the liver (Figure 3B)
and the phenotypic similarities of the DX5+ NK cells in the liver
and spleen (Supplemental Figure 2) indicate that CD49a+DX5–
NK cells stably reside in the liver sinusoidal space, whereas CD49a–
DX5+ NK cells are circulating NK cells passing through the liver
under noninflammatory homeostatic conditions.
CD49a+ NK cells confer hapten-specific CHS responses. The exclusive
and constitutive expression of CD49a by hepatic DX5– NK cells
in the steady state prompted us to examine the function of sensitized CD49a+ NK cells in CHS. The recipients of sensitized hepatic
CD49a+ NK cells displayed vigorous CHS responses after challenge, whereas recipients of the CD49a– subset failed to respond
(Figure 7A). Moreover, the magnitude of ear swelling showed a
nonstatistically significant positive trend for the number of trans-
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Figure 5
CD49a is a specific surface marker of liver-resident DX5– NK cells.
(A) Expression of CD49a, NKp46, CD51, CD27, CXCR6, and Thy1.2
versus DX5 was analyzed on NK1.1+CD3–CD19– cells or NK1.1+CD3–
cells from the indicated organs of WT or CXCR6+/– (for CXCR6 detection) mice. Data are representative of 4 to 6 individual mice. (B) DX5–
or DX5+ liver NK (NK1.1+ CD3– CD19–) cells (105) were sorted from
CD45.1+ mice and intravenously transferred into sublethally irradiated
CD45.2+ B6 mice. Seven days later, NK cells from recipient liver were
analyzed for the expression of CD45.1 and CD49a. Data are representative of 2 independent experiments. (C) Expression of CD49a was
analyzed on NK cells from unmanipulated BALB/c and Rag1–/– mice.
Numbers indicate the percentages of cells expressing CD49a among
NKp46+CD3–CD19– (BALB/c) or NK1.1+ (Rag1–/–) cells. Blue lines represent staining of the indicated molecules, and gray-shaded curves
represent isotype controls. Data are representative of 4 mice per group.
(D) As described in Methods, blood was collected from the unfractionated liver and other indicated sites from WT B6 mice, and then MNCs
were isolated. Expression of CD49a versus DX5 was analyzed on
NK1.1+CD3–CD19– cells. Plots are representative of at least 5 individual
mice. (E) Immunofluorescence histology of frozen sections of mouse
liver stained with anti-NKp46 (green), anti-CD31 (blue), anti-CD49a
(red), or anti-CD49b (DX5; red). Original magnification, ×250. (F) Histological analysis of Rag1–/– mouse liver stained with anti-CD49a (brown)
and NK1.1 (purple). Original magnification, ×320. (E and F) Data are
representative of at least 2 independent experiments.

ferred hepatic CD49a+ NK cells (Figure 7B). To confirm that the
recall responses conferred by hepatic CD49a+ NK cells were hapten specific, we adoptively transferred hepatic CD49a + NK cells
from OXA- or FITC-primed mice into WT recipients. Only when
challenged with the sensitizing hapten were the recipients able to
mount hapten-specific CHS responses; otherwise, the recipients
were unresponsive (Figure 7, C and D). These data indicate that the
hepatic CD49a+ NK cells confer hapten-specific CHS responses.
During the memory phase, however, we found that CD49a–DX5+
NK cells dramatically increased in the liver and were predominant at the ears after challenge (data not shown). Surprisingly,
CD49a+DX5– NK cells were still absent in the blood, and NK cells
at the site of ear swelling after challenge were predominantly
CD49a–DX5+ by flow cytometric analysis (Supplemental Figure 7
and data not shown), which raise the possibility that liver-resident
CD49a+DX5– NK cells may change their phenotype into CD49a–
DX5+ NK cells upon exiting the liver, or at the site of inflammation, or they may alternatively cooperate with other cells in the
effector phase of CHS.
Liver-resident HPCs differentiate into CD49a+DX5– NK cells. Since
NK cells are commonly considered to be derived from BM
hematopoietic stem cells (BM HSCs) throughout adult life, syngeneic BM transplantation (syn-BMT) was performed to investigate the developmental pathway of hepatic DX5– NK cells. In
contrast to the enrichment of DX5– NK cells in the livers (nearly
50%) of normal mice, very few DX5– NK cells (less than 15%) were
found in the livers of syn-BM transplanted mice even 3 months
after BMT (Figure 8A), suggesting that DX5– NK cells are not predominantly derived from BM. We then transplanted liver MNCs
into lethally irradiated mice, and surprisingly, liver MNCs as well
as BM HSCs, supported the survival of irradiated mice (Figure
8B), suggestive of the existence of HSCs in the liver. To further
address whether the liver contains precursors for this unique NK
subset, we adoptively transferred a mixture of BM cells containing heterozygous CD45.1+CD45.2+ double-positive (DP) BM cells

and homozygous CD45.1+ single-positive (SP) liver MNCs at a 1:1
ratio into lethally irradiated homozygous CD45.2+ mice (Figure
8C). DP and SP cells in recipients were analyzed 1 month after
BMT. Interestingly, liver MNC–derived SP cells were preferentially
found in the liver rather than in other organs, but BM-derived DP
NK cells were found mainly in the non-liver organs (Supplemental Figure 8). In contrast to the predominance of the DX5+ subset
among DP NK cells differentiated from BM-HSCs, SP NK cells
derived from liver MNCs were primarily DX5– (Figure 8D), further suggesting that the HPCs in hepatic liver MNCs are critical
for the generation of hepatic DX5– NK cells. In order to exclude
the influence of homeostatic proliferation by donor NK cells, we
also transferred purified hepatic CD45.1+ non-T, non-B, non-NK
precursors (CD3–CD19–NK1.1– cells) together with supporting
Nfil3–/– BM cells (e.g., NK cell–deficient BM) to lethally irradiated
recipients. CD49a+DX5– NK cells were generated in the recipient
liver 1 month after transfer (Figure 8E), demonstrating that there
are unique direct precursors of the hepatic DX5– NK cell subset in
the liver, and that the hepatic microenvironment supports their
further development. Moreover, the presence of CD49a–DX5+
NK cells originating from donor hepatic precursors in the liver
of recipients indicates that the liver also contains HPCs for conventional NK cell development. Thus, these results suggest that
the liver harbors NK1.1–CD3–CD19– HPCs, which are capable of
generating liver-resident CD49a+DX5– NK cells, whereas BM cells
are deficient in giving rise to this NK subset.
Discussion
In this study, we identified a unique NK cell subset residing essentially only in the liver sinusoids, characterized by the CD49a+DX5–
phenotype and endowed with memory capacity. Previous findings that “memory” NK cells were restricted to the liver (16, 17)
have generated much interest but have been somewhat puzzling
regarding their phenotype. Experiments of cell depletion by various antibodies (16) and adoptive transfer with different NK cell
subsets (17, 20, 33) had identified markers potentially associated
with memory, such as Thy1.2, Ly49C/I, CXCR6, and CD27, but
they were also expressed by splenic NK cells, which did not confer
memory. Our finding of the exclusive presence of CD49a+DX5–
NK cells in the liver with memory capacity adds strong support to
the concept that only hepatic NK cells, but not splenic NK cells,
confer CHS responses.
Although we found other molecules that tended to be expressed
on hepatic DX5– NK cells, such as TRAIL, we provide evidence that
CD49a could be used as a preferred marker of liver-resident NK
cells. This is likely to be the case in other mouse strains, such as
BALB/c mice, because CD49a is not known to be a polymorphic
molecule, unlike NK1.1. CD49a associates with the integrin β1
subunit (CD29) to form the CD49a/CD29 (VLA-1) heterodimer, a
major receptor for type IV collagen. Previous reports indicate that
constitutive VLA-1 expression is largely restricted to mesenchymal
cells, including smooth muscle cells, stellate cells, and hepatocytes
(34–36). In the immune system, resting leukocytes seldom express
VLA-1 (37), with the exception of the liver-resident NK cells
described here. More recently published studies, however, found
that viral infection induced T cells to express VLA-1, which was
required for retention and survival of antigen-specific memory T
cells in extralymphatic tissues (38, 39). In addition, CD49a expression was upregulated in both memory NK cells and memory CD8+
T cells in the MCMV infection model (40), suggesting that CD49a
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Figure 6
Minimal exchange of liver CD49a+DX5– NK cells in parabiotic mice. WT B6 (CD45.2) mice were parabiosed to congenic B6-CD45.1 mice. At day
14 postsurgery, the spleen and liver were harvested and flow cytometry was performed. (A) Representative dot plot of the liver and spleen gated
on live CD3–NK1.1+ cells followed by a CD45.1 gate (left panels) and CD45.2 gate (right panels) for each parabiont as indicated. The percentages
of CD49a+DX5– and CD49a–DX5+ cells are shown in the dot plots. (B) The percentages of CD49a+DX5– and CD49a–DX5+ cells in the liver and
spleen from A are depicted in the stacked bar graph which represents 7 parabiotic pairs. The CD49a+DX5– NK cells are indicated by the solid
shading, and the CD49a–DX5+ NK cells are indicated by the open box, with each column representing the indicated parabiont, according to the
CD45.1+ or CD45.2+ gate.

may be a common marker for memory lymphocytes. Future studies to dissect the role of CD49a in hepatic NK cell function will
therefore require NK cell–specific deletion of CD49a.
In the BM, DX5– NK cells are usually considered to be immature
NK cells, since they express intermediate levels of many surface
markers compared with NKP and DX5+ NK cells (7). Moreover,
DX5– NK cells transferred to sublethally irradiated NK1.1– mice
(11) or immunodeficient Il2rg–/–Rag2–/– mice (22) can generate
DX5+ NK cells. In contrast, our data presented here show that
hepatic DX5– NK cells remain CD49a+DX5– upon transfer to sublethally irradiated syngeneic mice. These results further indicate
that DX5 alone cannot be used to discriminate immature BM NK
cells from liver NK cells, and the liver CD49a+DX5– NK cells are
stable under steady-state circumstances.
Of note, compared with the CD49a +DX5– subset selectively
located in the liver, CD49a–DX5+ NK cells are the predominant
NK cell population in the peripheral organs, and they are phe1452

notypically similar regardless of organ isolation, suggesting that
they populate different organs through the systemic circulation.
By contrast, we did not find CD49a+DX5– NK cells in the afferent or efferent blood of the liver. Moreover, we found that the
CD49a+DX5– NK cells reside in the sinusoidal blood of the liver. In
addition, our data show that, after adoptive transfer, CD49a+DX5–
NK cells preferentially accumulated in the liver and did not
migrate to the spleen, whereas there was no tissue specificity for
DX5+ NK cells. Finally, our parabiosis experiments indicate that
the unmanipulated CD49a+DX5– NK cells are generally confined
to the liver and do not freely circulate, unlike the CD49a–DX5+ NK
cells that are found in the liver due to their propensity to circulate
freely. These findings indicate that under steady-state conditions,
CD49a+DX5– NK cells are the resident NK cell population of the
liver, whereas CD49a–DX5+ NK cells are a migratory subset, raising
the possibility that other tissues may have organ-specific NK cell
subsets that may be diluted by migratory CD49a–DX5+ NK cells.
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Figure 7
CD49a+ NK cells have the capacity to confer hapten-specific CHS
responses. (A) Naive B6 mice received 8 × 104 CD49a+ or CD49a–
liver NK cells from OXA-sensitized WT mice and were challenged 1
month later (n = 4 per group). (B) Naive B6 mice received the indicated
number of CD49a+ liver NK cells from OXA-sensitized WT mice and
were challenged 1 month later (n = 3 per group). (C and D) Naive B6
mice received 8 × 104 CD49a+ or CD49a– liver NK cells from OXA–sensitized (C), or FITC–-sensitized (D) WT mice and were challenged
with OXA or FITC 1 month later as indicated (n = 4 for the FITC plus
OXA group; n = 5 for the other groups). All data are from 1 experiment
representative of 2 independent experiments. *P < 0.05, **P < 0.01,
and ***P < 0.001, unpaired Student’s t test (A, C, and D), or ANOVA
(B). Means ± SEM of ear swelling are shown in all panels.

The liver has long been known to harbor large numbers of NK
cells, and previous studies have suggested that liver NK cells are
somewhat different from conventional NK cells (6, 11, 22, 41).
However, definitive features that distinguish liver and conventional NK cells were not identified previously. Our studies also
suggest that CD49a+DX5– NK cells may be related to the morphologically identified “pit” cells, which were first demonstrated
in rat liver (42) and are now known to be NK cells that reside in
the liver sinusoids. The blood flow within liver sinusoids (43) is
low, perhaps allowing the CD49a+DX5– NK cells to be retained in
the liver by adhesion molecules and thus not take up residence at
other sites.
Although BM is generally considered as the primary organ for
NK cell generation and development, our results presented here
indicate an alternative developmental pathway for liver-resident
NK cells. The low frequency of donor hepatic DX5– NK cells after
BMT suggests that BM is deficient in generating liver-resident NK
cells. The survival of lethally irradiated mice receiving liver MNCs
and the generation of CD49a+DX5– NK cells from liver-resident
HPCs strongly support the hypothesis that the liver contains the
precursors of liver-resident NK cells. Furthermore, liver HPCs are
much more effective at giving rise to hepatic DX5– NK cells than
BM cells, implying that liver-resident NK cells originate primarily
from the liver rather than from the BM. Indeed, during fetal life,
NK cell development occurs in the liver, and CD49a+DX5– NK cells
are predominant (data not shown), leading to the possibility that
the “seeds” for CD49a+DX5– NK cells in the liver emerge very early
in life and persist with age.
Yet, these liver-resident CD49a+DX5– NK cells confer hapten-specific “memory,” suggesting that they must somehow become sensitized to haptens placed on the skin, perhaps by haptenated cells
that migrate to the liver. Our new findings thus raise this possibly
novel scenario that contrasts with traditional views of T cell priming and the current hypothesized scheme of NK cell “priming” in

the lymph node (15). Inasmuch as CD49a+DX5– NK cells are liver
resident, it is possible that NK cell “priming” occurs in the liver.
Consistent with this hypothesis, it should be noted that there are
very few NK cells in lymph nodes where we found essentially no
CD49a+DX5– NK cells and where we found that haptens, such as
FITC, readily traffic to the liver where they are associated with cells
having phenotypes typically displaying APC function. While our
data do not exclude that sensitization may result in the recruitment of CD49a+DX5– NK cells to the draining lymph node, sensitized liver CD49a+DX5– NK cells ultimately play a role in “memory” NK cell responses.
Interestingly, we found few CD49a+DX5– NK cells at the cutaneous site of hapten challenge. This surprising finding is likely
related to recent studies indicating differences in the histology of
T cell– versus NK cell–mediated CHS reactions, suggesting that
their effector mechanisms differ (18). Moreover, this study failed
to find NK cells at the CHS site, which contrasts with our finding that CD49a–DX5+ NK cells were at the CHS lesion, more in
line with other studies that described NK cells in the lesions (16).
Our findings may be due to further differentiation of the liver-resident CD49a+DX5– subset, with a loss of CD49a expression after
exiting the liver, or to other cells that are involved in the effector
phase of “memory” NK cell responses. Regardless, while these
postulated effects require further investigation, identification of
a unique subset of hepatic NK cells provides a new framework for
the understanding of NK cell “memory.”
Methods
Mice. B6 and BALB/c mice were purchased from the Shanghai Experimental Animal Center (Shanghai, China). Rag1–/– (B6) and GFP transgenic (B6)
mice were obtained from the Model Animal Research Center (Nanjing,
China), which obtained the mice from The Jackson Laboratory. CD45.1+,
B6.SJL, and Cxcr6–/– (Cxcr6 alleles replaced with cDNA encoding GFP;
B6 background) mice (44) were purchased from the Jackson Laboratory.
Cxcr6+/– mice were generated and bred in house. Nfil3+/– (B6) mice were
provided by Tak W. Mak (University of Toronto, Toronto, Ontario, Canada). Cxcr6+/–, CD45.1+CD45.2+, and Nfil3–/– mice were bred in house. We
maintained mice in a specific pathogen-free facility for use according to
the guidelines for experimental animals at the University of Science and
Technology of China and Washington University.
Antibody staining and flow cytometry. We purchased FITC–anti-Ly49C/I/
F/H, FITC–anti-CD94, PE–anti-CD29, PE–anti-TRAIL, PerCP CY5.5–antiCCR7, and purified anti-CX3CR1 from eBioscience, and PE–anti-CCR6
from R&D Systems. All other antibodies for flow cytometry were purchased from BD Biosciences. Prior to staining with antibodies, cells were
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Figure 8
The liver retains HPCs capable of generating CD49a+DX5– NK cells. (A) Lethally irradiated CD45.2+ B6 mice that received 2 × 106 BM cells from
CD45.1+ B6 mice were analyzed for the expression of DX5 on hepatic CD45.1+ NK (NK1.1+CD3–CD19–) cells. Means ± SEM are shown (n = 3 for
each time point). (B) Survival of lethally irradiated B6 mice that received 3 × 106 BM cells (BMT), liver MNCs (LT), or splenocytes (ST). Lethally
irradiated mice without transplantation were set as the control group. Means ± SEM are shown (n = 5 per group). (C and D) Lethally irradiated
CD45.2+ B6 mice received 106 CD45.1+CD45.2+ (DP) BM cells mixed with 106 CD45.1+CD45.2– (SP) liver MNCs. One month after transfer, DP
and SP cells in the recipient livers were respectively gated to analyze the expression of DX5 on NK cells. Means ± SEM are shown (n = 3 per
group). (E) BM cells (2 × 106) from Nfil3–/– mice mixed with 105 hepatic NK1.1–CD3–CD19– cells from CD45.1+ B6 mice were transferred into
lethally irradiated CD45.2+ B6 mice. One month after transfer, CD45.1+ NK cells in the recipient livers were analyzed for the expression of DX5
and CD49a. All data are representative of 2 independent experiments.

incubated with rat immunoglobulin for 30 minutes to block Fc receptors.
We performed flow cytometry on an LSR II (BD Biosciences), and analyzed data with FlowJo software (Tree Star). To assess IFN-γ production,
we treated liver MNCs with recombinant human IL-2 (1,000 U/ml; Kingsley) and murine recombinant IL-12 (10 ng/ml; PeproTech) for 18 hours,
and added monensin (10 μg/ml; Sigma-Aldrich) during the last 4 hours.
Cells were then collected and stained for surface markers. After fixation
and permeabilization, cells were intracellularly stained with PE–anti-IFN-γ.
For CD107a analysis, liver MNCs were incubated with YAC-1 cells at a ratio
of 1:1 with monensin (10 μg/ml) and PE–anti-CD107a for 4 hours before
staining with other antibodies.
Cell preparation. Liver MNCs were isolated essentially as described previously (45). Briefly, we passed livers through a 200-gauge stainless steel
mesh. The cells were resuspended in 40% Percoll (GE Healthcare), then
gently overlaid onto 70% Percoll and centrifuged at 1,260 g for 30 minutes.
Liver MNCs were collected from the interphase. Splenocytes were isolated
by forcing the spleen through stainless steel mesh and subsequently lysing
erythrocytes. We obtained BM cells by flushing femurs and then lysing
1454

erythrocytes. PBMCs were obtained by lysing erythrocytes of the blood.
Lymphocytes of inguinal lymph nodes (iLNs) were obtained by mechanical disruption. Hepatocytes and Kupffer cells were isolated using a 2-step
collagenase perfusion method as described previously (46).
Cell sorting and transfer. A FACSAria cell sorter (BD Biosciences) was
used to purify NK cells or different NK cell subsets. Purity of sorted cell
populations was more than 95%, as verified by post-sort flow cytometry. For the study of CHS, we used unirradiated or lethally irradiated
(12 Gy given 1 day before adoptive transfer) WT B6 mice that received
intravenous injection of hepatic NK cell subsets, splenic NK cells, or liver
MNCs. To study the trafficking and development of liver NK cells, we
sublethally irradiated (6.5 Gy given 1 or 2 days before adoptive transfer)
CD45.2+ B6 mice which then received intravenously or intraperitoneally
delivered liver MNCs, purified DX5–, or DX5+ liver NK cells from CD45.1+
or GFP+ B6 mice. For BMT models, lethally irradiated WT B6 mice were
intravenously given CD45.1+ BM cells alone, CD45.1+CD45.2+ BM cells
plus CD45.1+CD45.2– liver MNCs, or Nfil3–/– BM cells plus CD45.1+CD3–
CD19–NK1.1– liver cells, respectively.
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CHS. On days 0 and 1, the shaved abdominal skin of mice was painted
with 50 μl 5% OXA (Sigma-Aldrich) in a solution of acetone/methanol (1:1)
or 0.5% FITC (Sigma-Aldrich) in dibutylphthalate. These mice were used as
donors for cell sorting and transfer on day 4. One month later, the right ear
of recipients was challenged with 20 μl 1% OXA or 0.5% FITC, and their left
ear was painted with vehicle. Ear thickness was measured every 24 hours
with a micrometer. To account for acute hapten-induced irritation, background swelling was measured in the naive mice, which did not receive
sensitized donor cells. Antigen-specific ear swelling was calculated as follows: (treated ear thickness – control ear thickness) – background swelling.
Migration of FITC carrier cells. Rag1–/– or WT B6 mice were sensitized on
days 0 and 1 by painting their shaved abdominal skin with 100 μl 0.5%
FITC. On day 2, sensitized mice were analyzed by flow cytometry for examination of FITC+ cells in different tissues.
Gene expression profile analysis of NK cell subsets. We sorted DX5–NK1.1+CD3–
cells and DX5+NK1.1+CD3– cells from the liver of naive B6 WT mice. For
each sample, we extracted total RNA using Trizol (Invitrogen), then purified RNA using the RNeasy Mini Kit (QIAGEN). We confirmed RNA quality and absence of genomic DNA contamination with a Bioanalyzer (Agilent Technologies). RNA from each sample was processed with 2-round
amplification according to standard Affymetrix protocols, and then
hybridized to mouse 430 2.0 chips (Affymetrix). Fluorescence was detected
with the Affymetrix GeneChip Scanner 3000 and image analysis was done
using Affymetrix GeneChip Operating Software (GCOS). For functional
classification of differentially expressed genes, we analyzed data using
terms from the Gene Ontology (GO) project.
Surgical methods to collect blood from different vessels. Mice were
intraperitoneally injected with pentobarbital sodium (75 mg/kg; Merck)
for anesthetization. To obtain portal venous blood and postcaval venous
blood, we collected about 150 μl of blood from portal vein or postcaval
vein in the abdominal cavity using scalp vein needles and negative-pressure
tubes. We transected the thoracic aorta to collect aortic blood. The postcaval vein in the thoracic cavity, the portal vein, and the hepatic artery were
ligatured with wire before the thoracic aorta was cut to exclude interference of sinusoidal blood in the liver. After collecting thoracic aortic blood,
we transected the postcaval vein in the abdominal cavity and collected the
outflowing sinusoidal blood.
Immunofluorescence. Frozen sections of liver (10-μm) were fixed in
a cold mixture of methanol/acetone (1:1) for 10 minutes. After fixation, an FcR-blocking step was performed with purified anti-CD16/32
(BD Biosciences) at room temperature for 30 minutes. For confocal
immunofluorescence of hepatic CD49a+ NK cells and endothelial cells, sections were stained with eFluor 660–anti-NKp46 (eBioscience), PE-labeled
CD49a (BD Biosciences), and eFluor450–anti-CD31 (eBioscience) at room
temperature for 60 minutes. For confocal immunofluorescence of hepatic
DX5– NK cells and endothelial cells, sections were stained with PE–antiNKp46 (eBioscience), APC–anti-CD49b (BD Biosciences), and eFluor 450–
anti-CD31 (eBioscience). Stained sections were examined using a Carl Zeiss
LSM 710 microscope. The antibodies mentioned above were dissolved in
3% BSA/PBS and used in a dilution of 1:100.
Histology. Liver specimens from Rag1 –/– mice were fixed in 4%
paraformaldehyde, dehydrated with a graded series of alcohol, and
embedded in paraffin. Seven-micrometer-thick paraffin sections were
de-paraffinized and hydrated. For peroxidase blocking, sections were
incubated in 3% hydrogen peroxidase in PBS for 10 minutes at room
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temperature and the sections were rinsed 3 times in PBS. We performed
serum blocking by incubating the sections in goat serum for 30 minutes at room temperature. Sections were then incubated in anti-CD49a
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